Skip to main content
. 2013 Jun 13;2013:657016. doi: 10.1155/2013/657016

Table 3.

Evolution of lesions in patients (n = 32) with cutaneous leishmaniasis secondary infections.

Evolution of lesions after treatments, n = patients, n/32 = (%)
New lesion Relapses
Patients Doses Remission, weeks Patients Doses Remission, weeks
SRa 4 (12.5) None 8.50 ± 3.41 3 (9.37) None 4.7 ± 3.0
1 (3.12) 10, Glub 10
Glub 7 (21.87) 27.4 ± 16.1 8.71 ± 2.49 4 (12.5) None 6.33 ± 1.52
3 (9.37) 25 ± 10, Glub 6.5 ± 3.79

aSR: spontaneous remission. bGlu: meglumine antimoniate or Glucantime.